Institut Claudius Regaud IUCT-O

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Cervical cancer1 trial
• Head and neck cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Terminated2 trials
• Completed1 trial

Lead sponsor

• ARCAGY/ GINECO GROUP1 trial
• EMD Serono Research & Development Institute, Inc.1 trial
• UNICANCER1 trial

Closed trials

• Terminated

  Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib

  NCT05625087· Phase 2· UNICANCER· Source

• Terminated

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· Phase 3· EMD Serono Research & Development Institute, Inc.· Source

• Completed

  COL Immunotherapy Before Radiochimio + Ipilimumab

  NCT04256213· ARCAGY/ GINECO GROUP· Source